Autologous stem cell transplantation is still a valid option in good- and intermediate-risk AML: a GITMO survey on 809 patients autografted in first complete remission

Saraceni, F ; Bruno, B ; Lemoli, R M ; Meloni, G ; Arcese, W ; Falda, M ; Ciceri, F ; Alessandrino, E P ; Specchia, G ; Scimè, R ; Raimondi, R ; Bacigalupo, A ; Bosi, A ; Onida, F ; Rambaldi, A ; Bonifazi, F ; Olivieri, A

Bone marrow transplantation (Basingstoke), 2017-01, Vol.52 (1), p.163-166 [Periódico revisado por pares]

England: Nature Publishing Group

Texto completo disponível